Heart Failure & SGLT2is: The New Pillar in Care

Description

This activity was planned with a goal to change the trajectory of SGLT2i use by providing practical guidance for cardiologists who are familiar with the clinical trial evidence, but unsure of how to safely use these drugs. The Heart Failure & SGLT2is: The New Pillar in Care course provides participants with the ability to:

Review current HF patient management challenges.
Distinguish pathophysiologic characteristics of HF, including new categorizations.
Identify the role of SGLT2 in the prevention and treatment of HF.
Compare and contrast GDMT for HF.
Customize the treatment plan for HFrEF patients.
Customize the treatment plan for HFpEF patients. 
Identify the interprofessional team strategies for improving care coordination and communication.

Table of Contents

Challenges in HF Management
Pathophysiology
SGLT2is for Heart Failure Prevention
Guideline Directed Medical Therapy for Heart Failure
Customized Treatment Plan for HFrEF
Customized Treatment Plan for HFpEF
Team-Based Care for HF
HF and Lifestyle Modifications: Best in Class

Summary


Availability:	On-Demand
	Expires on Dec 01, 2024


Cost:	FREE


Credit Offered:	No Credit Offered


Contains:	8 Courses